Cart
sales@molnova.com
glycine
CAS No. 56-40-6
glycine( AZD-4282 | AZD 4282 | Aminoacetic acid )
Catalog No. M18816 CAS No. 56-40-6
Glycine is a non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 37 | In Stock |
|
| 1G | 43 | In Stock |
|
Biological Information
-
Product Nameglycine
-
NoteResearch use only, not for human use.
-
Brief DescriptionGlycine is a non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter.
-
DescriptionAZD-4282, also known as aminoacetic acid and glycine, is a N-methyl-D-aspartate (NMDA) receptor antagonist potentially for the treatment of neuropathic pain.
-
In Vitro——
-
In Vivo——
-
SynonymsAZD-4282 | AZD 4282 | Aminoacetic acid
-
PathwayAngiogenesis
-
TargetHER/HSP
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number56-40-6
-
Formula Weight75.06
-
Molecular FormulaC2H5NO2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 25 mg/mL (333.02 mM)
-
SMILESC(C(=O)O)N
-
Chemical Nameglycine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Johnson JW, et al. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature. 1987 Feb 5-11;325(6104):529-31.
molnova catalog
related products
-
Trastuzumab
Trastuzumab is a humanized monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab has been clinically used to treat HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer.
-
BMS 599626 2HCl (873...
BMS 599626 2HCl (873837-23-1(HCl)) (AC480 dihydrochloride) is a selective inhibitor of HER1 and HER2 (IC50s: 20 nM and 30 nM), ~8-fold less potent to HER4, >100-fold to Lck, VEGFR2, c-Kit, MET, etc.
-
TAS0728
TAS0728 is a HER2 inhibitor with antitumor activity.
